Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 3-4
  • >
  • Efficacy of citalopram in more than maximal dose in drug-resistant depression. The treatment outcome after switching into the escitalopram. Case report

Archive 1995–2023

2006, volume 22, issue 3-4
Case report

Efficacy of citalopram in more than maximal dose in drug-resistant depression. The treatment outcome after switching into the escitalopram. Case report

Łukasz Święcicki1
1. II Klinika Psychiatryczna Instytutu Psychiatrii i Neurologii w Warszawie
Farmakoterapia w Psychiatrii i Neurologii, 2006, 3–4, 187–190
Keywords: citalopram, escitalopram, drug-resistant depression, over-maximal dose
Summary

A case report of 30 years white man with chronic, drug-resistant depression, was presented. The condition resolved during treatment with citalopram, 100 mg/day (against medical advise). There was no side effects. Results of debryzochine test show activity of CYP2D6 to be in normal range. After switching into the escitalopram, after two years of citalopram treatment, it would be possible to change the dosing to 10 mg per day, without adversive effects on to the psychiatric status.

Correspondence address
Łukasz Święcicki
Instytut Psychiatrii i Neurologii
Al. Sobieskiego 9, 02-957 Warszawa
tel. (022) 45 82 522
e-mail: [email]swiecick@ipin.edu.pl[/email]
You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links